Tags: Drug.

Galiximab is a monoclonal antibody designed for the treatment of B-cell lymphoma. As of September 2009 it is undergoing Phase III clinical trials. The drug is a chimeric antibody from Macaca irus and Homo sapiens.

ATC prefix
none
CAS number
357613-77-5
FDA UNII code
S9OX9692ZB

Loading...

This page contains content from the copyrighted Wikipedia article "Galiximab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.